| 1 | GNL2, MDN1, MKI67
|
| RNAmetasome network for macromolecule biogenesis in human cells
|
| Iuchi S, Paulo JA.
|
| Commun Biol. Dec 15;4(1):1399. doi: 10.1038/s42003-021-02928-y. 2021
|
| 2 | MKI67
|
| Ki-67 gene expression
|
| Uxa S, Castillo-Binder P, Kohler R, Stangner K, Müller GA, Engeland K.
|
| Cell Death Differ. Dec;28(12):3357-3370. doi: 10.1038/s41418-021-00823-x. Epub 2021 Jun 28 2021
|
| 3 | MKI67
|
| Ki-67 acts as a biological surfactant to disperse mitotic chromosomes.
|
| Cuylen S, Blaukopf C, Politi AZ, Müller-Reichert T, Neumann B, Poser I, Ellenberg J, Hyman AA, Gerlich DW.
|
| Nature. Jul 14;535(7611):308-12. doi: 10.1038/nature18610. Epub 2016 Jun 29 2016
|
| 4 | MKI67
|
| Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer
|
| Falato C, Lorent J, Tani E, Karlsson E, Wright PK, Bergh J, Foukakis T.
|
| Breast Cancer Res Treat. Sep;147(2):407-14. doi: 10.1007/s10549-014-3096-2. Epub 2014 Aug 17 2014
|
| 5 | EZH2, MKI67
|
| Enhancer of zeste homologue 2 expression in breast carcinoma smears in relationship with p53, Ki-67 and other prognostic parameters.
|
| Athanassiadou AM, Tsipis A, Patsouris E, Gonidi M, Nicolopoulou-Stamati P, Chelidonis G, Athanassiadou P.
|
| Acta Cytol 55(2):180-6. Epub 2011 Feb 15.
2011
|
| 6 | FOXP1, MKI67
|
| Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma.
|
| Toma MI, Weber T, Meinhardt M, Zastrow S, Grimm MO, Füssel S, Wirth MP, Baretton GB.
|
| Cancer Invest 29(2):123-9. Epub 2011 Jan 6.
2011
|
| 7 | KIT, MKI67, TP53
|
| CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma.
|
| Erler BS, Presby MM, Finch M, Hodges A, Horowitz K, Topilow AA, Matulewicz T.
|
| Tumour Biol 32(1):107-11. Epub 2010 Nov 8.
2011
|
| 8 | MKI67
|
| Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer.
|
| Rahmanzadeh R, Rai P, Celli JP, Rizvi I, Baron-Lühr B, Gerdes J, Hasan T.
|
| Cancer Res 70(22):9234-42. Epub 2010 Nov 2.
2010
|
| 9 | MKI67, TP53
|
| Immunohistochemical study of p53 and Ki67 in a group of patients with mammary carcinoma.
|
| Pleşan DM, Georgescu CV, Pătrană N, Pleşan C, Stoica D.
|
| Rom J Morphol Embryol 51(3):459-65.
2010
|
| 10 | MKI67
|
| Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
|
| Ladstein RG, Bachmann IM, Straume O, Akslen LA.
|
| BMC Cancer 10:140.
2010
|
| 11 | MKI67
|
| Characterization of endoglin and Ki-67 expression in endothelial cells from benign and malignant lesions of the uterine cervix.
|
| Cimpean AM, Saptefrati L, Ceausu R, Raica M.
|
| Pathol Int 59(10):695-700.
2009
|
| 12 | MKI67, TP53
|
| Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
|
| Talghini S, Halimi M, Baybordi H.
|
| Pak J Biol Sci 12(12):929-33.
2009
|
| 13 | KRAS, MKI67
|
| Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas.
|
| Woo T, Okudela K, Yazawa T, Wada N, Ogawa N, Ishiwa N, Tajiri M, Rino Y, Kitamura H, Masuda M.
|
| Lung Cancer 65(3):355-62. Epub 2009 Jan 21.
2009
|
| 14 | MKI67
|
| Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma.
|
| Hasselblom S, Ridell B, Sigurdardottir M, Hansson U, Nilsson-Ehle H, Andersson PO.
|
| Leuk Lymphoma 49(8):1501-9.
2008
|
| 15 | MKI67
|
| Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma.
|
| Wangsa D, Ryott M, Avall-Lundqvist E, Petersson F, Elmberger G, Luo J, Ried T, Auer G, Munck-Wikland E.
|
| Br J Cancer 99(7):1121-8. Epub 2008 Sep 2.
2008
|
| 16 | BCL2, MKI67, TP53
|
| Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
|
| Looi ML, Dali AZ, Ali SA, Ngah WZ, Yusof YA.
|
| Anal Quant Cytol Histol 30(2):63-70.
2008
|
| 17 | MKI67
|
| Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
|
| Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED.
|
| Cancer 110(4):783-90.
2007
|
| 18 | MKI67
|
| Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders.
|
| Bryant RJ, Banks PM, O'Malley DP.
|
| Histopathology 48(5):505-15.
2006
|
| 19 | CAMR, DIPK2B, ITPK1, MFF, MKI67, MRX92, MRXSSD, PHF16, PLLP, SLC9A7, TM4SF11P, VEZT, ZNF673, ZNF674
|
| An integrated, functionally annotated gene map of the DXS8026-ELK1 interval on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders.
|
| Thiselton DL, McDowall J, Brandau O, Ramser J, d'Esposito F, Bhattacharya SS, Ross MT, Hardcastle AJ, Meindl A.
|
| Genomics 79(4):560-72. Erratum in: Genomics 2002 Jun;79(6):891. 2002
|
| 20 | BCL2, CCNA1, CCNB1, CCND1, CDKN1A, CDKN2A, MKI67, RB1
|
| Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
|
| Kanavaros P, Stefanaki K, Rontogianni D, Papalazarou D, Sgantzos M, Arvanitis D, Vamvouka C, Gorgoulis V, Siatitsas I, Agnantis NJ, Bai M.
|
| Histol Histopathol 16(4):1005-12. 2001
|
| 21 | MKI67
|
| The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.
|
| Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, Gerdes J.
|
| J Cell Biol 123(3):513-22. 1993
|
| 22 | MKI67
|
| Assignment of the human Ki-67 gene (MKI67) to 10q25-qter.
|
| Fonatsch C, et al.
|
| Genomics 11 : 476-477. 1991
|
| 23 | MKI67
|
| Assignment of the gene(s) involved in the expression of proliferation-related Ki-67 antigen to human chromosome 10.
|
| Schonk DM, et al.
|
| Hum Genet 83 : 297-299. 1989
|